Endocr Pract. 2019 May;25(5):470-476. doi: 10.4158/EP-2018-0489. Epub 2019 Jan 18.
The natural biochemical history of untreated primary hyperparathyroidism (PHPT) is poorly understood. The purpose of this study was to determine the extent of biochemical fluctuations in patients with PHPT. Retrospective cohort study from January 1, 1995, to December 31, 2014. Serum calcium and parathyroid hormone (PTH) levels in patients with classic (Ca >10.5 mg/dL, PTH >65 pg/mL) and nonclassic (Ca >10.5 mg/dL, PTH 40 to 65 pg/mL) PHPT were followed longitudinally at 1, 2, and 5 years. Biochemical profiles in follow-up were ranked in descending biochemical severity as classic PHPT, nonclassic PHPT, normal calcium with elevated PTH (Ca <10.5 mg/dL, PTH >65 pg/mL), possible PHPT (Ca >10.5 mg/dL, PTH 21 to 40 pg/mL), or absent PHPT (Ca >10.5 mg/dL, PTH <21 pg/mL or Ca <10.5 mg/dL, PTH <65 pg/mL). Of 10,598 patients, 1,570 were treated with parathyroidectomy (n = 1,433) or medications (n = 137), and 4,367 were censored due to study closure, disenrollment, or death. In the remaining 4,661 untreated patients with 5 years of follow-up, 235 (5.0%) progressed to a state of increased biochemical severity, whereas 972 (20.8%) remained the same, and 3,454 (74.1%) regressed to milder biochemical states. In 2,522 untreated patients with classic PHPT, patients most frequently transitioned to the normal calcium with elevated PTH group (n = 1,257, 49.8%). In 2,139 untreated patients with nonclassic PHPT, patients most frequently transitioned to the absent PHPT group (n = 1,354, 63.3%). PHPT is a biochemically dynamic disease with significant numbers of patients exhibiting both increases and decreases in biochemical severity. = interquartile range; = Kaiser Permanente Southern California; = primary hyperparathyroidism; = parathyroid hormone; = parathyroidectomy.
未经治疗的原发性甲状旁腺功能亢进症(PHPT)的自然生化演变过程尚不清楚。本研究旨在确定 PHPT 患者的生化波动程度。
这是一项回顾性队列研究,纳入了 1995 年 1 月 1 日至 2014 年 12 月 31 日期间的患者。对经典 PHPT(Ca>10.5mg/dL,PTH>65pg/mL)和非经典 PHPT(Ca>10.5mg/dL,PTH 40-65pg/mL)患者的血清钙和甲状旁腺激素(PTH)水平进行了 1、2 和 5 年的纵向随访。根据生化严重程度将随访中的生化谱降序排列为经典 PHPT、非经典 PHPT、血钙正常伴 PTH 升高(Ca>10.5mg/dL,PTH>65pg/mL)、可能的 PHPT(Ca>10.5mg/dL,PTH 21-40pg/mL)或无 PHPT(Ca>10.5mg/dL,PTH<21pg/mL 或 Ca<10.5mg/dL,PTH<65pg/mL)。
在 10598 例患者中,有 1570 例接受了甲状旁腺切除术(n=1433)或药物治疗(n=137),4367 例因研究结束、失访或死亡而被删失。在其余 4661 例接受 5 年随访的未经治疗的患者中,有 235 例(5.0%)进展为生化严重程度增加的状态,972 例(20.8%)保持不变,3454 例(74.1%)生化状态缓解至较轻。在 2522 例未经治疗的经典 PHPT 患者中,患者最常过渡到血钙正常伴 PTH 升高组(n=1257,49.8%)。在 2139 例未经治疗的非经典 PHPT 患者中,患者最常过渡到无 PHPT 组(n=1354,63.3%)。
PHPT 是一种生化上动态的疾病,有相当数量的患者表现出生化严重程度的增加和减少。
=四分位间距;=凯撒永久南加州;=原发性甲状旁腺功能亢进症;=甲状旁腺激素;=甲状旁腺切除术。